Clinical Trials Logo
  1. Home
  2. Thrombolysis
  3. NCT03785678

Tenecteplase in Stroke Patients Between 4.5 and 24 Hours — TIMELESS  

THROMBOLYSIS Clinical Trial

Official title:
A Phase III, Prospective, Double-blind, Randomized, Placebo-controlled Trial of Thrombolysis in Imaging-eligible, Late-window Patients to Assess the Efficacy and Safety of Tenecteplase (TIMELESS)

Clinical Trial Summary

This study will evaluate the efficacy and safety of tenecteplase compared with placebo in participants with acute ischemic stroke (AIS). All participants will receive standard-of-care therapy according to AmericanHeart Association/American Stroke Association clinical guidelines (2018). To determine eligibility for randomization, all participants will undergo multimodal CT or MRI at baseline. Only participants with a vessel occlusion (ICA or MCA M1/M2) and penumbral tissue will be randomized. The primary analysis is to compare the efficacy of tenecteplase versus placebo in all participants at Day 90.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03785678
Study type Interventional
Source Genentech, Inc.
Contact
Status Completed
Phase Phase 3
Start date March 2, 2019
Completion date February 28, 2023
View Details
See also
  Status Clinical Trial Phase
Completed NCT03104062 - Effect of Ticagrelor and Clopidogrel on Coronary Microcirculation in Patients With Acute Myocardial Infarction N/A
Completed NCT04925869 - Prospective Study of Cerebrovascular Accidents (CVA) in 3 French Cities (Besançon, Cayenne and Tours)
Recruiting NCT03901872 - Contemporary Endovascular Therapies in Treatment of Acute Iliofemoral Deep Vein Thrombosis
Recruiting NCT05424978 - Application of Standardized Green Channel Treatment System for Ischemic Stroke in Xi 'an
Not yet recruiting NCT03166059 - CaveoVasc Thrombolysis Protection System, Access Protection Study N/A
Completed NCT02576379 - The Impact of a Helicopter Emergency Medical System on Prognosis in Stroke Patients N/A
Recruiting NCT06149520 - A Study to Learn More About How Well BAY3018250 Works and How Safe it is for People With Proximal Deep Vein Thrombosis Phase 2
Recruiting NCT02926742 - Submassive Pulmonary Embolism Experience With EKOS N/A
Recruiting NCT06221371 - Endovascular Treatment With or Without Preceding Intravenous Tenecteplase (TNK) in Patients With Late-window acUte Ischemic Stroke Due to Middle Cerebral Artery Occlusion Phase 3
Active, not recruiting NCT01665885 - Hypothermia in Acute Ischemic Stroke - Surface Versus Endovascular Cooling (HAIS-SE) Phase 2